19-41850617-A-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001040283.3(DMRTC2):c.908A>T(p.Asp303Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000298 in 1,613,420 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000031 ( 0 hom. )
Consequence
DMRTC2
NM_001040283.3 missense
NM_001040283.3 missense
Scores
1
9
9
Clinical Significance
Conservation
PhyloP100: 4.56
Genes affected
DMRTC2 (HGNC:13911): (DMRT like family C2) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in germ cell development; regulation of transcription by RNA polymerase II; and sex differentiation. Predicted to act upstream of or within male gamete generation and positive regulation of histone H3-K9 methylation. Predicted to be located in XY body. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.21778798).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DMRTC2 | NM_001040283.3 | c.908A>T | p.Asp303Val | missense_variant | 8/9 | ENST00000269945.8 | NP_001035373.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DMRTC2 | ENST00000269945.8 | c.908A>T | p.Asp303Val | missense_variant | 8/9 | 1 | NM_001040283.3 | ENSP00000269945 | P1 | |
DMRTC2 | ENST00000596827.5 | c.1061A>T | p.Asp354Val | missense_variant | 7/8 | 2 | ENSP00000469525 | |||
DMRTC2 | ENST00000599022.1 | n.374A>T | non_coding_transcript_exon_variant | 1/2 | 3 | |||||
DMRTC2 | ENST00000601660.5 | c.*426A>T | 3_prime_UTR_variant, NMD_transcript_variant | 7/7 | 2 | ENSP00000472159 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151956Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
151956
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000559 AC: 14AN: 250648Hom.: 0 AF XY: 0.0000959 AC XY: 13AN XY: 135518
GnomAD3 exomes
AF:
AC:
14
AN:
250648
Hom.:
AF XY:
AC XY:
13
AN XY:
135518
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461464Hom.: 0 Cov.: 33 AF XY: 0.0000481 AC XY: 35AN XY: 727030
GnomAD4 exome
AF:
AC:
46
AN:
1461464
Hom.:
Cov.:
33
AF XY:
AC XY:
35
AN XY:
727030
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151956Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74190
GnomAD4 genome
AF:
AC:
2
AN:
151956
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74190
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2022 | The c.908A>T (p.D303V) alteration is located in exon 8 (coding exon 7) of the DMRTC2 gene. This alteration results from a A to T substitution at nucleotide position 908, causing the aspartic acid (D) at amino acid position 303 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;N
REVEL
Benign
Sift
Pathogenic
.;D
Sift4G
Uncertain
D;T
Polyphen
D;D
Vest4
MutPred
Gain of methylation at K353 (P = 0.0379);.;
MVP
MPC
0.87
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at